Related Experiment Video
Updated: Feb 28, 2026

08:34
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
50.7K
Binocular Therapy for Childhood Amblyopia Improves Vision Without Breaking Interocular Suppression
Manuela Bossi1, Vijay K Tailor2, Elaine J Anderson3
1UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Investigative Ophthalmology & Visual Science
|June 15, 2017
Summary
Balanced binocular viewing therapy (BBV) offers a home-based treatment for amblyopia (lazy eye), showing high compliance and significant visual acuity gains. These improvements may not solely depend on reducing interocular suppression.
Area of Science:
- Ophthalmology
- Neuroscience
- Pediatrics
Background:
- Amblyopia, or lazy eye, is a common visual impairment affecting children.
- Current treatments often involve patching or blurring one eye, leading to poor patient compliance.
- Novel binocular treatments show promise for rapid visual gains, potentially by reducing interocular suppression.
Purpose of the Study:
- To develop an effective, home-based binocular treatment for amblyopia.
- To ensure high compliance with the treatment regimen.
- To investigate the role of interocular suppression in treatment response.
Main Methods:
- Balanced binocular viewing therapy (BBV) utilized dichoptic movies and gameplay for daily treatment.
- Treatment compliance and suppression levels were monitored remotely.
- Twenty-two children (3-11 years) with anisometropic or strabismic amblyopia participated.
Main Results:
- BBV demonstrated high compliance rates (89.4% of prescribed dose).
- Patients achieved a mean visual acuity improvement of 0.27 logMAR in the amblyopic eye.
- Acuity gains were not significantly correlated with reductions in interocular suppression.
Conclusions:
- Home-based BBV is an effective treatment for amblyopia, yielding substantial visual benefits.
- The therapy is well-tolerated and can be self-administered with remote monitoring.
- The findings suggest that mechanisms beyond reduced suppression contribute to BBV's effectiveness.
Related Concept Videos
Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Ophthalmic Drug Delivery Systems
102
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
102

